Payers Should Brace For Next Hepatitis C Drug “Onslaught” – Express Scripts
This article was originally published in The Pink Sheet Daily
Executive Summary
Express Scripts anticipates that the launch of new treatments in 2014 will replicate some of the dynamics in the hepatitis C market in 2011.